Quinoline derivatives as pi3 kinase inhibitors

Details Quinoline derivatives as pi3 kinase inhibitors Quinoline derivatives as pi3 kinase inhibitors

C - Chemistry, Metallurgy

07

D

C07D 401/14 (2006.01) A61K 31/4709 (2006.01) A61K 31/495 (2006.01) A61K 31/5377 (2006.01) A61P 35/00 (2006.01) C07D 401/10 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 471/04 (2006.01) C07D 493/04 (2006.01) C07D 498/04 (2006.01)

Patent

CA 2686016

Invented is a method of inhibiting the activity/function of PB kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative discase, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.

Procédé d'inhibition d'activité/de fonction de PI3 kinases reposant sur l'utilisation de dérivés de quinoline. Également, procédé de traitement, par administration de dérivés de quinoline, d'une ou plusieurs maladies pouvant être: troubles autoimmunes, maladies inflammatoires, cardio-vasculaires, neurodégénératives, allergie, asthme, pancréatite, défaillance de plusieurs organes, maladies rénales, agrégation plaquettaire, cancer, motilité du sperme, rejet de transplant, rejet de greffon, et lésions pulmonaires.

Affiliated with

Also associated with

Rating

Quinoline derivatives as pi3 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline derivatives as pi3 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as pi3 kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1784947